NXGL - NEXGEL Operating income before deduction of amortization

Public company logo of NEXGEL (NXGL)

NEXGEL, Inc. (NXGL) effective management controls costs while expanding the B2B segment, and its developments in polymer chemistry are modernizing the healing materials market. Absolute EBITDA dynamics clearly demonstrate daily cash flows, while the 0.00 metric confirms the current level of operating profit. The issuer's financial stability relies on steady demand from clinics for specialized hydrogel consumables.

NEXGEL, Inc. (NXGL) - Profit before payment of interest, taxes and amortization from 11/23/2025 to 11/10/2026
Product sample of NEXGEL Inc.

Patent protection for hydrogel compositions and FDA certification create a high barrier to entry for NEXGEL, Inc. (NXGL), ensuring a steady stream of funds. By analyzing absolute profit from core operations, an investor assesses the business's real ability to generate cash before deducting capital expenditures and taxes, which allows this chart to determine the sustainability of cash flow and the issuer's long-term operational efficiency.

Competitors of NEXGEL, Inc. (NXGL)

Income before deduction of interest, taxes and amortization ISRG|Danaher Corp. - Operating profit EBITDA|Operating income before deduction of amortization bd.com BDX|STERIS (STE) - Profit before payment of interest, taxes and amortization|Operating profit before amortization WST|Profit before payment of interest, taxes and amortization Baxter Corp|Masimo Inc. (MASI) - Operating income before deduction of amortization|Operating profit before deduction of amortization STVN (Stevanato Group S.p.A.)|Company profit before taxes, interest and amortization TFX|Profit before payment of interest, taxes and amortization Merit Medical MMSI|Income before deduction of interest, taxes and amortization NVST|ICUI: Operating profit before deduction of amortization|XRAY - Operating profit EBITDA|LeMaitre Vascular, Inc. (LMAT) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization atricure.com|STAA (STAAR Surgical) - Operating profit EBITDA|Profit before interest, taxes and amortization ChromaDex Corp NAGE|Profit before payment of interest, taxes and amortization ZimVie Dental (ZIMV)|AngioDynamics Inc. - Operating profit before amortization|Cerus Corporation - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization TKNO (teknova.com)|MGRM - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Sharps Technology, Inc. STSS|infusystem.com (INFU) - Profit before payment of interest, taxes and amortization|Operating profit before amortization UTMD|KRMD (KORU Medical Systems, Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization nyxoah.com NYXH|Operating profit before deduction of amortization MBOT (Microbot Medical)|Pro-Dex Inc - Operating profit before amortization|Operating profit EBITDA ZTEK (Zentek Limited)|Operating profit before depreciation charges Elutia Corporation|Milestone Scientific - Operating profit EBITDA|Profit before interest, taxes and amortization Retractable Technologies|Harvard Bioscience (HBIO) - Profit before payment of interest, taxes and amortization|FEMY (Femasys Inc) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization MHUA|POAI: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CJMB|Operating income before deduction of amortization atrioncorp.com|Profit before payment of interest, taxes and amortization NeuroMetrix NURO